Loading...
TDAY is not a good buy right now for an impatient investor. Despite bullish longer-term moving averages, near-term momentum is weakening (negative and expanding MACD histogram) and the stock is trading below/near the pivot (5.975) with immediate resistance overhead (6.149–6.256). With no news catalysts, no notable institutional/insider momentum, and deteriorating YoY revenue/margins, the risk/reward is not attractive for an immediate entry.
Price/levels: Post-market 5.92, sitting below the pivot 5.975; near-term support at 5.801 then 5.694; resistance at 6.149 then 6.256. Trend/momentum: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), implying a constructive broader trend, but momentum is deteriorating: MACD histogram is -0.029 and negatively expanding (bearish near-term). RSI_6 at 51.28 is neutral (no oversold bounce signal). Tactical read: This is a mixed setup—longer-term structure looks okay, but near-term momentum and price location (below pivot) do not support a chase entry now.
Intellectia Proprietary Trading Signals
suggests the broader trend has been constructive.
No news in the last week—no clear event-driven catalyst to re-rate the stock near-term.
Near-term momentum is bearish (MACD histogram below zero and expanding negatively).
2025/Q3 revenue declined -8.43% YoY and gross margin fell -7.96% YoY, which is a negative growth/mix signal.
No notable hedge fund or insider accumulation trend reported recently.
Latest quarter: 2025/Q3. Revenue declined to 560,796,000 (-8.43% YoY). Profitability improved versus last year but remained negative: Net Income -39,249,000 (improved ~99.71% YoY) and EPS -0.27 (improved ~92.86% YoY). Gross margin weakened to 29.47 (down ~7.96% YoY). Overall: improving losses, but top-line and margin trends are deteriorating.
No analyst rating or price-target change data was provided, so there is no clear read on recent Wall Street sentiment shifts. Based on the available fundamentals (declining revenue/margins but improving losses), pros would emphasize the narrowing losses/cost control, while cons would focus on shrinking revenue and margin compression.